Details for New Drug Application (NDA): 021548
✉ Email this page to a colleague
The generic ingredient in LEXIVA is fosamprenavir calcium. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the fosamprenavir calcium profile page.
Summary for 021548
Tradename: | LEXIVA |
Applicant: | Viiv Hlthcare |
Ingredient: | fosamprenavir calcium |
Patents: | 0 |
Suppliers and Packaging for NDA: 021548
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEXIVA | fosamprenavir calcium | TABLET;ORAL | 021548 | NDA | ViiV Healthcare Company | 49702-207 | 49702-207-18 | 60 TABLET, FILM COATED in 1 BOTTLE (49702-207-18) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 700MG BASE | ||||
Approval Date: | Oct 20, 2003 | TE: | RLD: | Yes |
Expired US Patents for NDA 021548
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viiv Hlthcare | LEXIVA | fosamprenavir calcium | TABLET;ORAL | 021548-001 | Oct 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Viiv Hlthcare | LEXIVA | fosamprenavir calcium | TABLET;ORAL | 021548-001 | Oct 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription